Guidelines for Authors
TUMOR (ISSN 1000-7431;CN31-1372/R) was founded in 1981 and is sponsored by Shanghai Cancer Institute, in which the State Key Laboratory of Oncogene & Related Genes and WHO Collaborating Center for Research on Cancer are involved. It is published monthly in Chinese.

TUMOR is a peer-reviewed publication reflecting the advance and progress of Chinese cancer research . The objective of TUMOR is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology and course of human cancer. The journal groups publications in the table of contents within the following categories : carcinogenesis, tumor biology and pathology, molecular biology and genetics, epidemiology and prevention, immunology and virology, or experimental therapeutics and clinical medicine. Review articles may also be published.

1. The acceptance criteria for all papers are the quality and originality of the research. Manuscripts are single-blind peer reviewed by two anonymous reviewers and the Editor. Final acceptance or rejection with the Editorial Board, who reserves the right to refuse any material for publication. All papers, regardless of type, represent the opinion of the authors and not necessarily that of the Editors, or the Publisher.

Papers reporting clinical studies should, where appropriate, contain a statement that they have been carried out with ethical committee approval. Papers disregarding the welfare of experimental animals will be rejected.

1. A paper is accepted for review by TUMOR on the understanding that:
2. * it has not been and will not be submitted simultaneously to another journal, in whole or in part
3. * it reports previously unpublished work
4. * all named authors have agreed to submit the paper to TUMOR in its present form
5. * if accepted, neither the paper itself nor substantial parts of it, will be published in the same form, in any language, without the consent of the publishers acting for the copyright holder.
6.  
7. A signed statement that all named authors have agreed to the submission and have participated in the study to a sufficient extent to be named as authors should accompany submitted manuscripts. If the authorship of a paper is changed in any way after it has been reviewed, the Editor will require a letter, signed by all authors named on either the original or the revised submission, explicitly agreeing to the change.
8.  
9. The Editors reserve the right to make literary corrections.